SCHEMBL7552932

SCHEMBL7552932

N#CC1(CC(=O)O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2805815 0.91 CYP2C19 (0.45)
SCHEMBL2807409 0.91 HSD11B1 (0.41)
SCHEMBL840651 0.89 CYP2C19 (0.48)
SCHEMBL3495245 0.89 CYP2C19 (0.48)
SCHEMBL3909670 0.87 CYP2C19 (0.47)
SCHEMBL14084349 0.79 HSD11B1 (0.40)
SCHEMBL17447343 0.78
SCHEMBL17294314 0.76 LMNA (0.35)
SCHEMBL4756992 0.76 HSD11B1 (0.42)
SCHEMBL4085736 0.76 HSD11B1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019422-A1 Cycloalkylalkanecarboxamides and their preparation and use WETTERICH FRANK (DE) 2002-02-14 US claimed
WO-2024204554-A1 SPIROCYCLIC MORPHINAN DERIVATIVE 日本ケミファ株式会社 2024-10-03 WO disclosed
CN-116444493-A Derivative containing double parallel rings, preparation method and application thereof 上海翰森生物医药科技有限公司 2023-07-18 CN disclosed
US-11661403-B2 Oxadiazole compounds VIVACE THERAPEUTICS, INC. (US) 2023-05-30 US disclosed
US-11453644-B1 Compounds ASTRAZENECA, AB (SE) 2022-09-27 US disclosed
EP-3390396-B1 ISOINDOLE COMPOUNDS ASTRAZENECA AB (SE) 2022-07-06 EP disclosed
CN-109071516-B Novel compounds 阿斯利康(瑞典)有限公司 2021-08-31 CN disclosed
US-20210238154-A1 OXADIAZOLE COMPOUNDS VIVACE THERAPEUTICS, INC. 2021-08-05 US disclosed
US-10988445-B2 Compounds ASTRAZENECA AB (SE) 2021-04-27 US disclosed
EP-3793551-A1 OXADIAZOLE COMPOUNDS Vivace Therapeutics, Inc. (US) 2021-03-24 EP disclosed
WO-2017102784-A9 ISOINDOLE COMPOUNDS ASTRAZENECA AB (SE) 2018-04-05 WO disclosed
EP-2865664-B1 NOVEL COMPOUND HAVING ABILITY TO INHIBIT 11B-HSD1 ENZYME OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT BAMICHEM CO LTD (KR) 2017-11-01 EP disclosed
WO-2017102784-A1 ISOINDOLE COMPOUNDS ASTRAZENECA AB (SE) 2017-06-22 WO disclosed
US-20170166527-A1 Novel Compounds ASTRAZENECA AB (SE) 2017-06-15 US disclosed
US-9464044-B2 Compound having ability to inhibit 11Beta-HSD1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient AHN-GOOK PHARMACEUTICAL CO., LTD. (KR) 2016-10-11 US disclosed
US-20150210635-A1 NOVEL COMPOUND HAVING ABILITY TO INHIBIT 11B-HSD1 ENZYME OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT INCHEON UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION (KR) 2015-07-30 US disclosed
EP-2865664-A1 NOVEL COMPOUND HAVING ABILITY TO INHIBIT 11B-HSD1 ENZYME OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT BAMICHEM CO., LTD (KR) 2015-04-29 EP disclosed
US-6410486-B2 FUNGICIDES BASF AKTIENGESELLSCHAFT (DE) 2002-06-25 US disclosed
US-20020019422-A1 Cycloalkylalkanecarboxamides and their preparation and use WETTERICH FRANK (DE) 2002-02-14 US disclosed
US-6265447-B1 FUNGICIDES BASF AKTIENGESELLSCHAFT (DE) 2001-07-24 US disclosed